Ceresola EM - Search Results

1

Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: comparison between different methods.

Chiappori A, Villalta D, Bossert I, Ceresola EM, Lanaro D, Schiavo M, Bagnasco M, Pesce G. Chiappori A, et al. Among authors: ceresola em. J Endocrinol Invest. 2010 Mar;33(3):197-201. doi: 10.1007/BF03346581. J Endocrinol Invest. 2010. PMID: 20418655

2

A study of the efficacy of radioiodine therapy with individualized dosimetry in Graves' disease: need to retarget the radiation committed dose to the thyroid.

Schiavo M, Bagnara MC, Calamia I, Bossert I, Ceresola E, Massaro F, Giusti M, Pilot A, Pesce G, Caputo M, Bagnasco M. Schiavo M, et al. J Endocrinol Invest. 2011 Mar;34(3):201-5. doi: 10.1007/BF03347067. Epub 2010 Dec 15. J Endocrinol Invest. 2011. PMID: 21164277

3

Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter.

Giusti M, Caputo M, Calamia I, Bagnara M, Ceresola E, Schiavo M, Mussap M, Ferone D, Minuto F, Bagnasco M. Giusti M, et al. Thyroid Res. 2009 Jun 30;2(1):6. doi: 10.1186/1756-6614-2-6. Thyroid Res. 2009. PMID: 19566933 Free PMC article.

4

Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study.

Cecoli F, Ceresola EM, Altrinetti V, Cabria M, Cappagli M, Montepagani A, Cuttica CM, Filippi U, Saverino D, Raffa M, Caputo M, Minuto F, Giusti M, Bagnasco M. Cecoli F, et al. Among authors: ceresola em. Eur Thyroid J. 2016 Sep;5(3):180-186. doi: 10.1159/000446746. Epub 2016 Jun 2. Eur Thyroid J. 2016. PMID: 27843808 Free PMC article.

5

A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma.

Giusti M, Sibilla F, Cappi C, Dellepiane M, Tombesi F, Ceresola E, Augeri C, Rasore E, Minuto F. Giusti M, et al. J Endocrinol Invest. 2005 Jul-Aug;28(7):599-608. doi: 10.1007/BF03347258. J Endocrinol Invest. 2005. PMID: 16218042

6

Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.

Giusti M, Cappi C, Santaniello B, Ceresola E, Augeri C, Lagasio C, Minuto F. Giusti M, et al. Minerva Endocrinol. 2006 Sep;31(3):191-209. Minerva Endocrinol. 2006. PMID: 17213787 English, Italian.

7

Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.

Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola E, Pivonello R, Albertelli M, Bianchi F, Giusti M, Minuto F. Ferone D, et al. J Endocrinol Invest. 2005;28(11 Suppl International):111-7. J Endocrinol Invest. 2005. PMID: 16625859 Review.

8

Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease.

Boschetti M, De Lucchi M, Giusti M, Spena C, Corallo G, Goglia U, Ceresola E, Resmini E, Vera L, Minuto F, Ferone D. Boschetti M, et al. Eur J Endocrinol. 2006 Jun;154(6):813-8. doi: 10.1530/eje.1.02161. Eur J Endocrinol. 2006. PMID: 16728540

9

Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.

Giusti M, Cecoli F, Fazzuoli L, De Franchis V, Ceresola E, Ferone D, Mussap M, Minuto F. Giusti M, et al. Metabolism. 2007 May;56(5):699-707. doi: 10.1016/j.metabol.2007.01.004. Metabolism. 2007. PMID: 17445547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters